-

OnLume Surgical is a Finalist for the 2020 Wisconsin Innovation Awards

MADISON, Wis.--(BUSINESS WIRE)--OnLume Surgical, a medical device company developing novel imaging systems for use during surgery, was recognized as one of the ten (10) finalists for the 2020 Wisconsin Innovation Awards.

Over 380 businesses, products and services from around Wisconsin were considered and nominated for the 2020 awards. Nominations spanned all parts of Wisconsin, representing large, medium and small companies, startups, established businesses, and nearly all industries.

OnLume has unique imaging technology to illuminate critical anatomy in real-time during surgery to optimize surgical precision, which can lead to improved patient outcomes, reduced morbidity and reduced costs.

The finalists were determined by a panel of 30 statewide industry experts, with winners to be announced on October 13, 2020 at a virtual awards ceremony. The Wisconsin Innovation Awards Ceremony is open to the public. Details on the program, event and registration are available at www.wisconsininnovationawards.com.

About OnLume Inc.: OnLume is a surgical device company which recently received its first FDA regulatory clearance to bring its fluorescence guided surgery (FGS) imaging system to market. The technology is cleared for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive and microsurgeries. OnLume is developing further applications of its imaging platform, including FGS for cancer surgery, in which tumor-specific drugs could deliver fluorescent dye to cancer cells to help surgeons identify residual cancer tissue that is otherwise invisible.

About the Wisconsin Innovation Awards: The Wisconsin Innovation Awards (WIA) connects and showcases innovators throughout the state of Wisconsin, across industries and organizations of all shapes and sizes. By producing and providing educational media content, organizing a statewide network of experts willing to mentor and support each other, and hosting events that highlight groundbreaking work, WIA is building a lasting legacy of instruction inspired by Wisconsin’s thinkers, makers, creators, and designers. WIA fosters innovation in this state and helps shine a light on companies throughout the state that have transformational ideas.

The Wisconsin Innovation Awards Ceremony is presented by Alliant Energy, American Family Insurance, and Wipfli. Additional support provided by Exact Sciences, Green Clock, JP Cullen, Neider & Boucher, Wisconsin Economic Development Corporation and the Wisconsin Union.

Contacts

James A. Bowman
Chief Executive Officer
jim.bowman@onlume.com
http://www.onlume.com/

OnLume Inc.


Release Versions

Contacts

James A. Bowman
Chief Executive Officer
jim.bowman@onlume.com
http://www.onlume.com/

More News From OnLume Inc.

OnLume Surgical Completes $7 Million Series A Financing

MADISON, Wis.--(BUSINESS WIRE)--OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to assist its plans for commercial launch. OnLume raised over $7 Million in this financing, adding to a $2 Million Phase II SBIR grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), awarded in late 2020. “The completion of the Series A financing, plus the Phase II...

OnLume Surgical Awarded $2 Million Grant from National Cancer Institute to Advance the Development of its Novel Fluorescence-Guided Surgery Device

MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical anatomy in real-time during surgery to optimize precision, which can lead to...

OnLume Surgical Participates in Clinical Trial Combining Fluorescence-Guided Surgery Imaging Device with Alume’s Novel Nerve-Targeting Agent

MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during surgery to optimize surgical precision, which can lead to improved patie...
Back to Newsroom